Contract opportunity

TRICARE Medicare Eligible Program Second Generation (TMEP2)

Combined Synopsis/Solicitation from Department of Defense.

Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.

Closing in 13 days

Notice details

Agency
Department of Defense
Sub-tier agency
DEFENSE HEALTH AGENCY (DHA)
Notice type
Combined Synopsis/Solicitation
Solicitation number
HT940226R0001
NAICS
524292 Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds
Product/service code
Q201
Posted
Sep 29, 2026
Response deadline
Nov 6, 2026
Source
SAM.gov

Description

25 Sep 2026: Uploaded signed version of the basic RFP and Amendment 0001 that updates the sensitivity labels of Section J, Attachment J-5b and Exhibits L-7, L-8, L-9. This acquisition is for the continuing requirement for health care claims processing, customer support and other associated administrative services (e.g. submission of TRICARE encounter data and provider certification) of dual-eligible Medicare and TRICARE beneficiaries who receive medical services within the United States, Puerto Rico, Guam, US Virgin Islands, American Samoa, and Northern Mariana Islands. USC Title 10, Chapter 55, and USC Title 32, National Defense, Code of Federal Regulations (CFR) Part 199, outline the benefit structure, administrative functions and the various health care programs, including TMEP2. This is a full and open competitive source selection, using best value trade-off procedures in accordance with RFO Federal Acquisition Regulation (RFO FAR) 15.2, Evaluation and Award, as supplemented with Defense FAR Supplement and the DoD Source Selection Procedures (August 2022). The contract awarded will be a Firm Fixed-Price contract. The contract will have a one 12-month base period of transiotion-in activiteis, seven 1-year periods for healthcare delivery, a one 12-month contract period for transition-out activities, and a potential 6-month extension of services permitted per RFO FAR Clause 52.217-8, Option to Extend Services, for a potential total period of performance of 8.5 years.

Summarized from the official notice.

Official notice

View on SAM.gov →

Requirements and amendments are controlled by the official notice.

DSE verdict

The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.

See DSE GovCon plans →

Get free alerts

Email alerts for notices like this one are free on DSE GovCon Intelligence.

Set up free alerts →

Frequently asked questions

When is the response deadline?

The published deadline is Nov 6, 2026. That is 13 days after the data date.

What NAICS code applies?

NAICS 524292, Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds.

Which agency issued this notice?

Department of Defense.

Where is the official notice?

The link under Official notice opens the source listing.